rs10925024 - NLRP3
Magnitude 2.2 · 1 study on file
Reported associations
-
Pleiotropic genetic architecture and novel loci for C-reactive protein levels - Unknown journal (n.d.) · Unknown authors · PubMed 36376304
ABSTRACT: C-reactive protein is involved in a plethora of pathophysiological conditions. Many genetic loci associated with C-reactive protein are annotated to lipid and glucose metabolism genes supporting common biological pathways between inflammation and metabolic traits. To identify novel pleiotropic loci, we perform multi-trait analysis of genome-wide association studies on C-reactive protein levels along with cardiometabolic traits, followed by a series of in silico analyses including colocalization, phenome-wide association studies and Mendelian randomization. We find 41 novel loci and 19 gene sets associated with C-reactive protein with various pleiotropic effects. Additionally, 41 variants colocalize between C-reactive protein and cardiometabolic risk factors and 12 of them display
Auto-generated from study metadata. AI-synthesised commentary is added when this entry is regenerated through content-service's LLM mode.
Lifestyle context
Concrete actions anchored to the cited research. We do not prescribe, we describe.
Discuss with your doctor
-
Cardiovascular risk assessment Moderate
NLRP3-associated elevated CRP warrants integrated cardiovascular risk evaluation to inform prevention strategy.
Screening
-
C-reactive protein levels Moderate
NLRP3 inflammasome variants associate with elevated C-reactive protein, a systemic inflammation marker and cardiovascular risk indicator.
Annual CRP measurement; include in cardiovascular screening.